Harrow Announces Offering of $250 Million Senior Unsecured Notes Due in 2030

NASHVILLE, Tenn.—Harrow (NASDAQ:HROW), a leading provider of ophthalmic disease management solutions in North America, announced that it has commenced with a private offering of $250 million aggregate principal amount in senior unsecured notes due in 2030, subject to market and other conditions. The 2030 Notes will be guaranteed on a senior unsecured basis by the company’s existing and future wholly owned domestic restricted subsidiaries, it stated, and any of its other restricted subsidiaries that guarantees or co-issues any of its indebtedness or any indebtedness of any of its subsidiaries that guarantees the 2030 Notes, subject to certain exceptions.